Return to content in this issue

 

H1-Antihistamines May No Longer Be Necessary for Patients With Refractory Chronic Spontaneous Urticaria After Initiation of Omalizumab

Ensina LF1,2, Arruda LK3, Campos RA4, Criado RF5, Rodrigues Valle S6, Melo JML3, Oliveira JCS4, Dortas Jr SD6, Cusato- Ensina AP1, Camelo-Nunes IC2, Agondi RC7

1CPAlpha Clinical Research Center, Barueri, Brazil
2Federal University of São Paulo, São Paulo, Brazil
3Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
4Federal University of Bahia, Salvador, Brazil
5Faculdade de Medicina do ABC, Santo André, Brazil
6Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
7Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

J Investig Allergol Clin Immunol 2020; Vol 30(2) : 145-147
doi: 10.18176/jiaci.0464

Key words: Urticaria, Therapeutics, Omalizumab, Histamine antagonists

Title Type Size
doi10.1876_jiaci.0464_material-suppl_1.pdf pdf 109.36 Kb